Reduced
0.15% → 0.13%
Oaktree Capital sold 833,000 shares; portfolio weight moved from 0.15% to 0.13%.
-833,000 Shares
-8.47%
REPLIGEN CORP is tracked here as a normalized 13F company record; no curated business description is available yet.
Original CUSIPs: 759916AD1. This page shows current managers, quarterly changes, and primary SEC sources.
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
Oaktree Capital sold 833,000 shares; portfolio weight moved from 0.15% to 0.13%.
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $5,769,918 | 5,796,000 | Oaktree Capital New position · 5,796,000 Shares |
| Q3 2025 | 1 | $8,892,576 | 8,822,000 | Oaktree Capital Increased · 8,822,000 Shares |
| Q4 2025 | 1 | $10,788,425 | 9,830,000 | Oaktree Capital Increased · 9,830,000 Shares |
| Q1 2026 | 1 | $8,790,069 | 8,997,000 | Oaktree Capital Reduced · 8,997,000 Shares |
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Oaktree Capital | REPLIGEN CORP | 759916AD1 | CONVERTIBLE BOND | $8,790,069 | 8,997,000 | 0.13% | SEC XML |